Brief: Tetra Bio-Pharma Initiates A Proof Of Concept Clinical Trial For Its Ophthalmic Drug In Dogs
Feb 20 (Reuters) - Tetra Bio-Pharma Inc TBP.V :
* TETRA BIO-PHARMA INITIATES A PROOF OF CONCEPT CLINICAL
TRIAL FOR
ITS OPHTHALMIC DRUG IN DOGS
* TETRA BIO PHARMA INC - TRIAL FOR ITS OPHTHALMIC DRUG IN
DOGS
EXPECTED TO BE COMPLETED BY APRIL 30, 2020
Source text for Eikon: ID:nGNX54Byyy
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding